Literature DB >> 17961565

Treatment of postpartum hemorrhage with misoprostol.

J Blum1, Z Alfirevic, G Walraven, A Weeks, B Winikoff.   

Abstract

A literature review was conducted to determine whether misoprostol is an effective treatment for postpartum hemorrhage (PPH) and in what dose. All English language articles published before March 2007 reporting on misoprostol for treatment of PPH were reviewed. Unpublished data previously presented at international scientific meetings were also included in the review. Little evidence exists in support of misoprostol for treatment of postpartum hemorrhage (PPH). Nonetheless, PPH remains a major killer of women worldwide, and new treatment options are widely sought. For this reason, we recommend a single dose of misoprostol 600 microg oral or sublingual for PPH treatment in instances when other treatments have either failed to work or are not available.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17961565     DOI: 10.1016/j.ijgo.2007.09.013

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  7 in total

1.  Evaluation of compliance and outcomes of a management protocol for massive postpartum hemorrhage at a tertiary care hospital in Pakistan.

Authors:  Lumaan Sheikh; Nida Najmi; Umair Khalid; Taimur Saleem
Journal:  BMC Pregnancy Childbirth       Date:  2011-04-13       Impact factor: 3.007

2.  Comparison effect of intravenous tranexamic acid and misoprostol for postpartum haemorrhage.

Authors:  Farnaz Sahhaf; Shamsi Abbasalizadeh; Morteza Ghojazadeh; Atefeh Velayati; Roya Khandanloo; Parviz Saleh; Reza Piri; Mohammad Naghavi-Behzad
Journal:  Niger Med J       Date:  2014-07

Review 3.  Efficacy of misoprostol for the treatment of postpartum hemorrhage: current knowledge and implications for health care planning.

Authors:  Ndola Prata; Karen Weidert
Journal:  Int J Womens Health       Date:  2016-07-29

4.  Heat-stable sublingual oxytocin tablets as a potential needle-free approach for preventing postpartum hemorrhage in low-resource settings.

Authors:  Changcheng Zhu; Marcus Estrada; Jessica White; Manjari Lal
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

5.  Helping rural women in Pakistan to prevent postpartum hemorrhage: a quasi experimental study.

Authors:  Ali Mohammad Mir; Abdul Wajid; Sadaf Gull
Journal:  BMC Pregnancy Childbirth       Date:  2012-10-30       Impact factor: 3.007

6.  Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan.

Authors:  Nadeem F Zuberi; Jill Durocher; Rozina Sikander; Neelofur Baber; Jennifer Blum; Gijs Walraven
Journal:  BMC Pregnancy Childbirth       Date:  2008-08-21       Impact factor: 3.007

7.  A Relative Bioavailability Study of Two Misoprostol Formulations Following a Single Oral or Sublingual Administration.

Authors:  Mahdi Amini; Margareta Reis; Dag Wide-Swensson
Journal:  Front Pharmacol       Date:  2020-02-12       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.